About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Denver | 7,462 Studies Near You

Clinical TrialsDenver

Clinical Trials in Denver

Discover 7,462 clinical trials near Denver, Colorado. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1321-1340 of 7,462 trials

CompletedStudy of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma PatientsTo explore whether Elotuzumab dose administration over approximately 60 minutes is feasible and safe.NCT02159365·Tucson, Arizona and 28 others TerminatedCodex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBCThis study, BC-819-18-204, is a Phase 2, open-label, monotherapy, single-arm, multicenter clinical trial of BC-819 (inodiftagene vixteplasmid) in patients with NMIBC adequately…NCT03719300·Anchorage, Alaska and 47 others

Find Trials by Condition in Denver

Breast Cancerin Denver Lung Cancerin Denver Prostate Cancerin Denver Colorectal Cancerin Denver Melanomain Denver Leukemiain Denver Lymphomain Denver Pancreatic Cancerin Denver Ovarian Cancerin Denver Brain Cancerin Denver Diabetesin Denver

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular RosaceaThe primary objective is to show that open-label extended treatment with FMX103 1.5%, for up to an additional 40 weeks, is safe and well tolerated.NCT03276936·Glendale, Arizona and 78 others

CompletedAn Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation ConversationsAn Implantable Cardioverter-Defibrillator (ICD) is a device implanted in a patient's chest to monitor the heart rhythm and deliver shocks to terminate potentially lethal…NCT01459744·Denver, Colorado and 5 others

CompletedA Survey of Complementary and Conventional Medicine Use Patterns in the Veteran PopulationIn this protocol, the investigators proposed to assess the Complementary Alternative Medicine (CAM) usage patterns in a Veteran population using a CAM survey developed by Dr…NCT01502475·Denver, Colorado and 1 other

Active not recruitingParesthesia-Free Fast-Acting Subperception (FAST) StudyStudy to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific…NCT04618471·Palm Desert, California and 12 others

CompletedA Randomized Trial of GM-CSF in Patients With ALI/ARDSThis study will test the hypothesis that administration of granulocyte-macrophage colony stimulating factor (GM-CSF) to patients with acute lung injury/acute respiratory distress…NCT00201409·Denver, Colorado and 2 others

CompletedSWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical TrialRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002900·Mobile, Alabama and 104 others

Active not recruitingRenal Mechanism of SGLT2 InhibitionCanagliflozin is an oral drug which is currently approved for use in patients with type 2 diabetes by the US Food and Drug Administration (FDA).NCT05507892·Aurora, Colorado and 1 other

Active not recruitingNKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDSThis is a single-arm, open-label, multi-center, Phase 1 study to determine safety and tolerability of an experimental therapy called NKX101 (allogeneic CAR NK cells targeting…NCT04623944·Denver, Colorado and 7 others

CompletedA Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular RosaceaThe primary objectives of this study are to determine the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.NCT04608500·Glendale, Arizona and 45 others

CompletedSafety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on MetforminThis study is intended to assess the effect on HbA1c of different dose regimens of LX4211 in combination with metformin in subjects with Type 2 Diabetes Mellitus who have…NCT01376557·Anaheim, California and 55 others

CompletedCeramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)This study is intended to gather short (Pre-operative to 4-years) and mid-term (5-years) information regarding the performance and safety of the commercially available 36mm…NCT02096211·Sacramento, California and 12 others

CompletedA Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced TumorsPart I will evaluate the pharmacokinetic profile and safety of KTN3379 over several doses with the objective of defining a Phase 2 dose in patients with advanced malignancies.NCT02014909·Denver, Colorado and 4 others

TerminatedClinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)This clinical study compares the efficacy, safety, and tolerability of therapy with ponesimod vs placebo in subjects with active RMS who are treated with DMF (Tecfidera®).NCT02907177·Birmingham, Alabama and 118 others

CompletedA Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPDThe purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.NCT00280371·Jasper, Alabama and 51 others

No longer availableA Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ TransplantationFacilitated access to everolimus until it is commercially available and reimbursable by appropriate partiesNCT00149981·Birmingham, Alabama and 152 others

Active not recruitingA Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)The main purpose of this study is to compare the clinical benefit, as measured by Progression-Free Survival (PFS), Objective Response Rate (ORR), and Overall Survival (OS)…NCT04008030·Los Angeles, California and 156 others

CompletedEffectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial DiseaseThis study is designed to develop a clinical registry of Peripheral Arterial Disease (PAD) patients undergoing lower extremity revascularization to describe the population and…NCT01588067·Denver, Colorado and 1 other

TerminatedPemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)The primary objective of the study is to determine whether pemafibrate administered twice daily will delay the time to first occurrence of any component of the clinical composite…NCT03071692·Birmingham, Alabama and 887 others

PreviousPage 67 of 374Next

Heart Diseasein Denver